Leadership Overview
Insulet has 10 executives leading key functions including strategy, finance, human resources, technology, operations, and customer experience.
Driven by innovation, Insulet is dedicated to simplifying the lives of individuals managing diabetes and other conditions through its pioneering Omnipod product platform, aiming to redefine subcutaneous drug delivery.
Driven by innovation, Insulet is dedicated to simplifying the lives of individuals managing diabetes and other conditions through its pioneering Omnipod product platform, aiming to redefine subcutaneous drug delivery.
Leadership Roles at Insulet
Ashley McEvoy - President, Chief Executive Officer & Director
Ashley McEvoy, the President, Chief Executive Officer & Director at Insulet, directs the company's overarching strategy and operational execution. McEvoy guides Insulet's mission to enhance the lives of individuals with diabetes through its innovative Omnipod Insulin Management System. This leadership role involves steering the company's expansion into new therapeutic areas by leveraging the Omnipod technology platform for non-insulin drug delivery. Overseeing all corporate functions, McEvoy ensures alignment with market demands and long-term growth objectives. The Chief Executive Officer drives critical decisions regarding product development, market penetration, and strategic partnerships, solidifying Insulet's position as a leader in wearable drug delivery technology. Ashley McEvoy's vision propels the company's commitment to simplifying complex medical treatments for patients globally.

Sagar Patel - Chief of Staff & Chief Executive Officer, Office
Sagar Patel, the Chief of Staff & Chief Executive Officer, Office at Insulet, provides strategic support and operational coordination across key executive initiatives. Patel works closely with the CEO and senior leadership to drive strategic projects, enhance organizational efficiency, and ensure effective communication across departments. This role is vital for translating high-level corporate objectives into actionable plans and facilitating seamless execution of the company's mission. The Chief of Staff, Office of the CEO plays a critical part in managing priorities, streamlining decision-making processes, and supporting the overall strategic direction of Insulet. Sagar Patel's contributions are essential for optimizing leadership effectiveness and advancing Insulet's commitment to simplifying diabetes care.
Carsten Boess - Chief Financial Officer
Carsten Boess, the Chief Financial Officer at Insulet, manages the company's financial health and strategic fiscal planning. Boess oversees all financial operations, including accounting, treasury, and investor relations, ensuring robust financial controls and reporting. This role is critical in supporting Insulet's growth initiatives and capital allocation strategies. The Chief Financial Officer works closely with the executive team to develop financial models that underpin product innovation and market expansion. Boess's responsibilities include managing budgets, forecasting financial performance, and optimizing the company's capital structure to support its mission of simplifying diabetes management. Carsten Boess's financial acumen is vital for sustaining Insulet's operational efficiency and driving shareholder value.
Ana Chadwick - Executive Vice President & Chief Financial Officer & Treasurer
Ana Chadwick, the Executive Vice President & Chief Financial Officer & Treasurer at Insulet, directs the company's comprehensive financial strategy and treasury operations. Chadwick is responsible for managing Insulet's financial planning, capital management, and investor relations, ensuring fiscal discipline and strategic resource allocation. This senior finance role is pivotal in supporting the company's ambitious growth objectives and its commitment to innovation in diabetes care. The Chief Financial Officer & Treasurer works to optimize the company's financial structure and secure the necessary capital for research, development, and global expansion. Ana Chadwick's financial leadership is essential for maintaining Insulet's strong market position and driving sustainable value creation.

Flavia Pease - Executive VP & Chief Financial Officer
Flavia Pease, the Executive VP & Chief Financial Officer at Insulet, leads the company's financial operations and strategic fiscal planning. Pease oversees all aspects of financial management, including budgeting, forecasting, and capital deployment, to support Insulet's mission of simplifying diabetes management. This executive position is crucial for driving financial performance and ensuring the company's long-term economic health. The Chief Financial Officer collaborates with other leaders to align financial strategies with business objectives, particularly in expanding the reach of the Omnipod platform. Flavia Pease's expertise is instrumental in guiding Insulet's financial decisions, enabling continued investment in product innovation and market growth.

Timothy Stonesifer - Chief Financial Officer, At Alcon Inc
Timothy Stonesifer, the Chief Financial Officer, At Alcon Inc at Insulet, oversees the financial strategy and operations for the company. Stonesifer is responsible for managing financial planning, reporting, and capital allocation to support Insulet's growth and innovation in medical devices. This executive role is critical in ensuring the financial stability and fiscal health of the organization, particularly as it expands its Omnipod product platform. The Chief Financial Officer works to optimize financial performance and drive value for stakeholders. Timothy Stonesifer's financial leadership guides Insulet's strategic investments and operational efficiencies, reinforcing its commitment to simplifying the lives of people with diabetes and other conditions.
Charles Alpuche - Chief Operating Officer & Vice Executive
Charles Alpuche, the Chief Operating Officer & Vice Executive at Insulet, oversees the company's global operational functions and manufacturing processes. Alpuche directs the execution of Insulet's production strategies, ensuring the efficient and high-quality manufacturing of the Omnipod Insulin Management System and other drug delivery devices. This executive position involves optimizing supply chain logistics, enhancing operational efficiency, and maintaining rigorous quality control standards across all manufacturing sites. The Chief Operating Officer plays a key part in scaling production to meet growing global demand for Insulet's innovative products. Charles Alpuche's leadership ensures that Insulet can reliably deliver its life-changing technologies to patients worldwide, supporting the company's mission to simplify diabetes care.
Elizabeth Davis - Senior VP & Chief Human Resources Officer
Elizabeth Davis, the Senior VP & Chief Human Resources Officer at Insulet, leads all human capital strategies and organizational development initiatives. Davis is responsible for cultivating a high-performance culture that supports Insulet's innovative spirit and patient-centric mission. This executive role encompasses talent acquisition, employee engagement, compensation and benefits, and leadership development across the organization. The Chief Human Resources Officer ensures that Insulet attracts, retains, and develops the talent necessary to drive its pioneering work in medical device technology. Elizabeth Davis's focus on people operations is integral to fostering an environment where employees can contribute effectively to the company's goals of simplifying diabetes care and expanding drug delivery solutions.

Rakesh Pant - Staff Software Engineer & Chief Technology Officer, Cloud Data Products
Rakesh Pant, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products at Insulet, spearheads the development and strategic direction of Insulet's cloud-based data solutions. Pant leads the engineering teams responsible for architecting, building, and maintaining the robust cloud infrastructure that powers Insulet's Omnipod platform and associated data services. This critical technology leadership role involves defining the technical roadmap for data products, ensuring scalability, security, and compliance. The Chief Technology Officer, Cloud Data Products drives innovation in data analytics and management, enabling enhanced insights for patients and healthcare providers. Rakesh Pant's technical expertise is fundamental to advancing Insulet's digital capabilities and supporting the seamless delivery of insulin and other subcutaneous drugs.
Nikkole DeMars - Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX)
Nikkole DeMars, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) at Insulet, directs comprehensive planning and operational strategies for end-to-end customer experience. DeMars focuses on optimizing customer journeys and ensuring seamless service delivery across all touchpoints of the Omnipod product platform. This leadership position involves coordinating cross-functional efforts to enhance customer satisfaction and loyalty. The Director, E2E CX Planning and Operations plays a key role in translating customer insights into operational improvements and strategic initiatives. Nikkole DeMars's dedication to customer experience excellence supports Insulet's goal of making life easier for individuals managing diabetes and other conditions.
Explore Leadership Teams in Manufacturing
Founded in 1990, Getinge is a Sweden-based company active in the healthcare sector. It provides products and services for intensive care units, sterilization centers, elderly care and companies and institutions active in the life sciences area.
Company Leadership CC
CH
AE
MM
Terumo is a global medical device company originating from Japan. The company pursues reliable quality and advanced technology to contribute to healthcare across countries and regions worldwide. It focuses on reducing patients’ difficulties both mentally and physically while delivering solutions that help address challenges in medical settings. Terumo remains committed to working alongside healthcare professionals to make meaningful contributions to society, now and into the future.
Company Leadership SU
PL
YK
KT
GE HealthCare is a global medical technology and healthcare solutions organization with a long heritage of innovation in the health care industry. The company is headquartered in the United States and has cultivated a reputation as a leading provider of technologies and services that support the diagnosis, treatment, and monitoring of patients across a wide range of clinical settings. GE HealthCare develops and delivers a broad portfolio of advanced products that includes imaging systems, patient monitoring tools, ultrasound equipment, ancillary devices used in interventional care, and pharmaceutical diagnostics that help clinicians visualize internal biological structures. The organization operates at the center of the healthcare ecosystem, aiming to improve productivity, expand access, and enhance outcomes in clinical environments by combining medical devices with digital solutions and services. Its offerings are designed to assist physicians and other healthcare professionals in delivering precise, timely, and actionable information, which supports key clinical decisions from initial screening through therapy and ongoing care. GE HealthCares technologies extend from sophisticated imaging platforms and visualization systems to remote patient monitoring solutions powered by data analytics and cloud-enabled tools.
Company Leadership BF
Medicom was founded in 1988. This company provides infection control product manufacturing. Their headquarters are located in Beaconsfield, Quebec, Canada.
Company Leadership MH
MH
BM